Starlight Therapeutics, a Subsidiary of Lantern Pharma Focused on CNS & Brain Cancers, Announces Dr. Marc Chamberlain as Chief Medical Officer

By /

Starlight Therapeutics today announced that Marc Chamberlain, M.D. has joined Starlight as its Chief Medical Officer.

Scroll to Top